BACKGROUND: Del Nido (DN) cardioplegic solution (CPS) has been widely used during pediatric cardiac surgery. However, its use in the field of adult cardiac surgery is not popular yet. We evaluated efficacy of DN cardioplegia in adult cardiac surgical patients. METHODS: Fifty-three adult patients (mean age, 54±16 years) who underwent cardiovascular surgery using DN cardioplegia were enrolled. Myocardial troponin I (TnI) level up to three days after surgery and early clinical outcomes were evaluated. Propensity score matching was performed to compare these results with those after surgery using blood cardioplegia (BC). RESULTS: DN cardioplegia was infused with an initial dose of 1,126±221 mL, and an additional 500 mL was reinfused in 15 patients 91 minutes after initial infusion. After release of aortic cross clamp (ACC), spontaneous defibrillation was achieved in 94.3% (50/53). The peak TnI level after surgery was 9.8 ng/mL (range, 2.0-90.2 ng/mL). Linear regression models demonstrated that neither left ventricular mass (LVM) nor ACC time was associated with increased level of peak TnI (P=0.928 and 0.595, respectively). Early mortality occurred in one patient (1.9%). Postoperative complications included atrial fibrillation (n=18, 34.0%), acute kidney injury (n=4, 7.5%), low cardiac output syndrome (n=1, 1.9%), and respiratory complications (n=1, 1.9%). Propensity score matching extracted 39 pairs. Spontaneous defibrillation was achieved more frequently in the DN than BC groups (37/39 vs. 12/39, P<0.001). Peak level and serial changes of TnI were not statistically different between the two groups (P=0.085 and 0.959, respectively). There were also no significant differences in early mortality and postoperative complication rates between the two groups. CONCLUSIONS: DN cardioplegia is as effective as BC for adult patients in terms of myocardial protection and early clinical outcomes.
BACKGROUND:Del Nido (DN) cardioplegic solution (CPS) has been widely used during pediatric cardiac surgery. However, its use in the field of adult cardiac surgery is not popular yet. We evaluated efficacy of DN cardioplegia in adult cardiac surgical patients. METHODS: Fifty-three adult patients (mean age, 54±16 years) who underwent cardiovascular surgery using DN cardioplegia were enrolled. Myocardial troponin I (TnI) level up to three days after surgery and early clinical outcomes were evaluated. Propensity score matching was performed to compare these results with those after surgery using blood cardioplegia (BC). RESULTS:DN cardioplegia was infused with an initial dose of 1,126±221 mL, and an additional 500 mL was reinfused in 15 patients 91 minutes after initial infusion. After release of aortic cross clamp (ACC), spontaneous defibrillation was achieved in 94.3% (50/53). The peak TnI level after surgery was 9.8 ng/mL (range, 2.0-90.2 ng/mL). Linear regression models demonstrated that neither left ventricular mass (LVM) nor ACC time was associated with increased level of peak TnI (P=0.928 and 0.595, respectively). Early mortality occurred in one patient (1.9%). Postoperative complications included atrial fibrillation (n=18, 34.0%), acute kidney injury (n=4, 7.5%), low cardiac output syndrome (n=1, 1.9%), and respiratory complications (n=1, 1.9%). Propensity score matching extracted 39 pairs. Spontaneous defibrillation was achieved more frequently in the DN than BC groups (37/39 vs. 12/39, P<0.001). Peak level and serial changes of TnI were not statistically different between the two groups (P=0.085 and 0.959, respectively). There were also no significant differences in early mortality and postoperative complication rates between the two groups. CONCLUSIONS:DN cardioplegia is as effective as BC for adult patients in terms of myocardial protection and early clinical outcomes.
Authors: Giuseppe Ristagno; Tong Wang; Wanchun Tang; Shijie Sun; Carlos Castillo; Max Harry Weil Journal: Crit Care Med Date: 2008-11 Impact factor: 7.598
Authors: Stephanie L Mick; Michael P Robich; Penny L Houghtaling; A Marc Gillinov; Edward G Soltesz; Douglas R Johnston; Eugene H Blackstone; Joseph F Sabik Journal: J Thorac Cardiovasc Surg Date: 2014-10-22 Impact factor: 5.209
Authors: J Darcy O'Brien; Susan E Howlett; Hayley J Burton; Stacey B O'Blenes; D Sharon Litz; Camille L Hancock Friesen Journal: Ann Thorac Surg Date: 2009-05 Impact factor: 4.330
Authors: Yasuhiro Kotani; James Tweddell; Peter Gruber; Christian Pizarro; Erle H Austin; Ronald K Woods; Colleen Gruenwald; Christopher A Caldarone Journal: Ann Thorac Surg Date: 2013-07-31 Impact factor: 4.330
Authors: Halit Yerebakan; Robert A Sorabella; Marc Najjar; Estibaliz Castillero; Linda Mongero; James Beck; Maliha Hossain; Hiroo Takayama; Mathew R Williams; Yoshifumi Naka; Michael Argenziano; Emile Bacha; Craig R Smith; Isaac George Journal: J Cardiothorac Surg Date: 2014-10-30 Impact factor: 1.637
Authors: Muhammad Farhan Ali Rizvi; Syed Muhammad Arslan Yousuf; Attaullah Younas; Mirza Ahmad Raza Baig Journal: Pak J Med Sci Date: 2022 Mar-Apr Impact factor: 1.088